RareCyte is a pioneering Life Sciences Precision Biology company that specializes in developing innovative technologies and products in the fields of spatial biology and liquid biopsy. With its groundbreaking Orion technology, RareCyte enables advanced tissue analysis through 20 channel whole-slide multiplex imaging, which has been embraced by leading research institutions and pharmaceutical companies globally for translational research, drug discovery, and clinical applications. The company is committed to driving market adoption of its cutting-edge solutions and fostering strong relationships with key opinion leaders in the research, translational, and clinical markets.